Hansen Medical has announced that the company’s Magellan Robotic System will be demonstrated at the forthcoming 38th annual VEITHsymposium at the Hilton New York in New York City from November 16 to 20.
Bruce Barclay, Hansen Medical’s president and CEO, said that the five-day annual symposium will be attended by interventionalists and vascular surgeons from around the globe. He also said that the Magellan Robotic System, which is already certified in Europe, will offer physicians more control and flexibility through independent distal tip control of a sheath and catheter as well as through robotic direction of a regular guidewire from a unified, remote workstation. This proprietary technology may also provide important clinical benefits to physicians by allowing predictable and precise catheter exploration of peripheral vessels.
Two demonstrations on Hansen Medical's robotics technology will be presented at the Cleveland Clinic-sponsored VEITHsymposium on November 18, 2011. Professor Nick Cheshire of St. Mary's Hospital, will present on "Advantages of a Robotic Guidance System for Catheter Steerage in the Performance of Fenestrated and Branched Endografting (The Hansen System)" from 6:58 a.m. to 7:03 a.m. and Professor Alan Lumsden of the DeBakey Heart & Vascular Center in Houston will present on "Advantages of the Hansen Remotely Steerable Catheter and Sheath System in Endovascular Procedures" from 7:15 a.m. to 7:20 a.m.
Besides, Hansen Medical will exhibit the NorthStar Robotic Catheter and the Magellan Robotic System and conduct product presentations.
The Magellan Robotic System created by Hansen Medical, is based upon the adaptable robotic technology included in the Sensei-X Robotic Catheter System presently being sold in Europe and the US.
Source: http://www.hansenmedical.com/